• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PO3
Click for more information
0.00% 22.0¢

PURIFLOH LIMITED - Announcements

Market Cap $7.078M  ! watchlist Created with Sketch. Add to my watchlist

PuriflOH Limited is an Australia-based company commercializing a global patented... PuriflOH Limited is an Australia-based company commercializing a global patented technology for purifying air, water and surfaces in residential, commercial and industrial applications. The Company’s principal activities include the development of its Free Radical Generator (FRG) technology for a range of applications, such as indoor air purification, water sanitation and medical sterilization. The FRG technology produces a range of reactive oxygen species (ROS) that include the hydroxyl radical, superoxide radical, oxygen radical and the ozone molecule. Its devices are engineered to control the plasma characteristics and selectively increase or decrease the production of specific oxygen and hydroxyl-based free radicals to target specific contaminants effectively without leaving toxic levels of any by-products. Its subsidiary is PuriflOH USA Incorporated.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
PO3 Half Yearly Report and AccountsPRICE SENSITIVE28/02/19
PO3 ** LEAVE ** Half Yearly Report and AccountsPRICE SENSITIVE28/02/19
PO3 Appendix 4C - quarterlyPRICE SENSITIVE29/01/19
PO3 Market Update - ActivitiesPRICE SENSITIVE23/01/19
PO3 Results of Meeting03/12/18
PO3 Chairman's Address to AGMPRICE SENSITIVE30/11/18
PO3 FRG Trials on TuberculosisPRICE SENSITIVE29/11/18
PO3 Formal License Agreement ExecutedPRICE SENSITIVE19/11/18
PO3 Initial Director's Interest Notice07/11/18
PO3 Change in substantial holding07/11/18
PO3 Becoming a substantial holder07/11/18
PO3 Cleansing Statement07/11/18
PO3 Appendix 3B07/11/18
PO3 Capital Raising and Director AppointmentPRICE SENSITIVE07/11/18
PO3 Trading HaltPRICE SENSITIVE06/11/18
PO3 November Presentation01/11/18
PO3 Appendix 4C - quarterlyPRICE SENSITIVE30/10/18
PO3 Proxy Form for Notice of AGM30/10/18
PO3 Notice of Annual General Meeting/Proxy Form30/10/18
PO3 Appendix 4E and Annual ReportPRICE SENSITIVE31/08/18
PO3 Initial Director's Interest Notice23/08/18
PO3 Appendix 4C - quarterlyPRICE SENSITIVE27/07/18 download Created with Sketch. 282.47KB
PO3 Change in substantial holding05/07/18 download Created with Sketch. 140.81KB
PO3 Appendix 3B05/07/18 download Created with Sketch. 335.56KB
PO3 Conversion of Notes05/07/18 download Created with Sketch. 160.14KB
PO3 Removal of Cigarette Smoke and OdourPRICE SENSITIVE26/06/18 download Created with Sketch. 483.58KB
PO3 Confirmation of Name Change14/05/18
PO3 Appendix 4C - quarterlyPRICE SENSITIVE30/04/18
PO3 Director Appointment and Management Update24/04/18
PO3 Results of General Meeting23/04/18
PO3 Aerosol Test ResultsPRICE SENSITIVE17/04/18
PO3 Notice of General Meeting/Proxy Form21/03/18
PO3 Proposed Name Change21/03/18
PO3 Half Yearly Report and AccountsPRICE SENSITIVE28/02/18
PO3 Update - Bluemist Test ResultsPRICE SENSITIVE13/02/18
PO3 Appendix 4C - quarterlyPRICE SENSITIVE31/01/18
PO3 Form 604 - Dilato22/12/17
PO3 Appendix 3B22/12/17
PO3 Appendix 3B22/12/17
PO3 Change of Director's Interests - Lill21/12/17
PO3 Change of Director's Interests - Annear21/12/17
PO3 Change of Director's Interests - Morris21/12/17
PO3 S Morris - Amended App 3X21/12/17
PO3 Amending App 3X21/12/17
PO3 Reinstatement to Official QuotationPRICE SENSITIVE18/12/17
PO3 Capital Raising CompletedPRICE SENSITIVE18/12/17
PO3 Suspension from Official QuotationPRICE SENSITIVE15/12/17
PO3 Trading HaltPRICE SENSITIVE13/12/17
PO3 Secures New Technology RightsPRICE SENSITIVE11/12/17
PO3 Share Consolidation Completed07/12/17
PO3 Results of Meeting24/11/17
PO3 Change of Director's Interest Notice21/11/17
PO3 Consolidation/Split - WRGPRICE SENSITIVE21/11/17
PO3 Appendix 4C - quarterlyPRICE SENSITIVE31/10/17
PO3 Notice of Annual General Meeting/Proxy Form25/10/17
PO3 Appendix 4EPRICE SENSITIVE31/08/17
PO3 Annual Report to shareholders31/08/17
PO3 Final Director's Interest Notice17/08/17
PO3 Initial Director's Interest Notice17/08/17
PO3 Director Appointment/Resignation17/08/17
PO3 Appendix 4CPRICE SENSITIVE28/07/17
PO3 Appendix 4C - Amended16/05/17
PO3 Appendix 4C - quarterlyPRICE SENSITIVE01/05/17
PO3 Technology Partner Somnio Presents to Flint Water Conference20/03/17
PO3 Appendix 4C - Amended06/03/17
PO3 Half Yearly Report and Accounts27/02/17
PO3 Appendix 4DPRICE SENSITIVE27/02/17
PO3 Appendix 4C - quarterlyPRICE SENSITIVE31/01/17
PO3 First Ozone Plant shipped for trialsPRICE SENSITIVE20/12/16
PO3 AGM Voting Results24/11/16
PO3 Market Update AGMPRICE SENSITIVE24/11/16
PO3 Appendix 4G14/11/16
PO3 Appendix 4C - quarterly-WRG.AX PRICE SENSITIVE28/10/16
PO3 Notice of General Meeting/Proxy Form-WRG.AX 25/10/16
PO3 Annual Report to shareholders-WRG.AX 30/09/16
PO3 Preliminary Final Report-WRG.AX PRICE SENSITIVE31/08/16
PO3 Appendix 4C - quarterly-WRG.AX PRICE SENSITIVE29/07/16
PO3 Appendix 4C - quarterly-WRG.AX PRICE SENSITIVE26/04/16
PO3 Market Update-WRG.AX PRICE SENSITIVE08/04/16
PO3 Half Yearly Report and Accounts29/02/16
PO3 Appendix 4DPRICE SENSITIVE29/02/16
PO3 Appendix 4CPRICE SENSITIVE29/01/16
PO3 Results of Meeting30/11/15
PO3 Appendix 4C - quarterlyPRICE SENSITIVE29/10/15
PO3 Notice of Annual General Meeting/Proxy Form28/10/15
PO3 Appendix 4G01/10/15
PO3 Annual Report to shareholders30/09/15
PO3 Preliminary Final ReportPRICE SENSITIVE31/08/15
PO3 Appendix 4C - quarterlyPRICE SENSITIVE28/07/15
PO3 Company Secretary Appointment/Resignation30/06/15
PO3 Results of Meeting28/05/15
PO3 Market Update28/05/15
PO3 Notice of Annual General Meeting/Proxy Form29/04/15
PO3 Quarterly Cashflow ReportPRICE SENSITIVE28/04/15
PO3 Annual Report31/03/15
PO3 2014 Preliminary Final ReportPRICE SENSITIVE27/02/15
PO3 Market UpdatePRICE SENSITIVE17/02/15
PO3 Appendix 4C - quarterlyPRICE SENSITIVE28/01/15
PO3 Market Update and Share Purchase Plan19/11/14
PO3 Appendix 4C - quarterlyPRICE SENSITIVE27/10/14
PO3 Half Yearly Report and Accounts
28/02/19PRICE SENSITIVE
PO3 ** LEAVE ** Half Yearly Report and Accounts
28/02/19PRICE SENSITIVE
PO3 Appendix 4C - quarterly
29/01/19PRICE SENSITIVE
PO3 Market Update - Activities
23/01/19PRICE SENSITIVE
PO3 Results of Meeting
03/12/18
PO3 Chairman's Address to AGM
30/11/18PRICE SENSITIVE
PO3 FRG Trials on Tuberculosis
29/11/18PRICE SENSITIVE
PO3 Formal License Agreement Executed
19/11/18PRICE SENSITIVE
PO3 Initial Director's Interest Notice
07/11/18
PO3 Change in substantial holding
07/11/18
PO3 Becoming a substantial holder
07/11/18
PO3 Cleansing Statement
07/11/18
PO3 Appendix 3B
07/11/18
PO3 Capital Raising and Director Appointment
07/11/18PRICE SENSITIVE
PO3 Trading Halt
06/11/18PRICE SENSITIVE
PO3 November Presentation
01/11/18
PO3 Appendix 4C - quarterly
30/10/18PRICE SENSITIVE
PO3 Proxy Form for Notice of AGM
30/10/18
PO3 Notice of Annual General Meeting/Proxy Form
30/10/18
PO3 Appendix 4E and Annual Report
31/08/18PRICE SENSITIVE
PO3 Initial Director's Interest Notice
23/08/18
PO3 Appendix 4C - quarterly
27/07/18PRICE SENSITIVE download Created with Sketch. 282.47KB
PO3 Change in substantial holding
05/07/18 download Created with Sketch. 140.81KB
PO3 Appendix 3B
05/07/18 download Created with Sketch. 335.56KB
PO3 Conversion of Notes
05/07/18 download Created with Sketch. 160.14KB
PO3 Removal of Cigarette Smoke and Odour
26/06/18PRICE SENSITIVE download Created with Sketch. 483.58KB
PO3 Confirmation of Name Change
14/05/18
PO3 Appendix 4C - quarterly
30/04/18PRICE SENSITIVE
PO3 Director Appointment and Management Update
24/04/18
PO3 Results of General Meeting
23/04/18
PO3 Aerosol Test Results
17/04/18PRICE SENSITIVE
PO3 Notice of General Meeting/Proxy Form
21/03/18
PO3 Proposed Name Change
21/03/18
PO3 Half Yearly Report and Accounts
28/02/18PRICE SENSITIVE
PO3 Update - Bluemist Test Results
13/02/18PRICE SENSITIVE
PO3 Appendix 4C - quarterly
31/01/18PRICE SENSITIVE
PO3 Form 604 - Dilato
22/12/17
PO3 Appendix 3B
22/12/17
PO3 Appendix 3B
22/12/17
PO3 Change of Director's Interests - Lill
21/12/17
PO3 Change of Director's Interests - Annear
21/12/17
PO3 Change of Director's Interests - Morris
21/12/17
PO3 S Morris - Amended App 3X
21/12/17
PO3 Amending App 3X
21/12/17
PO3 Reinstatement to Official Quotation
18/12/17PRICE SENSITIVE
PO3 Capital Raising Completed
18/12/17PRICE SENSITIVE
PO3 Suspension from Official Quotation
15/12/17PRICE SENSITIVE
PO3 Trading Halt
13/12/17PRICE SENSITIVE
PO3 Secures New Technology Rights
11/12/17PRICE SENSITIVE
PO3 Share Consolidation Completed
07/12/17
PO3 Results of Meeting
24/11/17
PO3 Change of Director's Interest Notice
21/11/17
PO3 Consolidation/Split - WRG
21/11/17PRICE SENSITIVE
PO3 Appendix 4C - quarterly
31/10/17PRICE SENSITIVE
PO3 Notice of Annual General Meeting/Proxy Form
25/10/17
PO3 Appendix 4E
31/08/17PRICE SENSITIVE
PO3 Annual Report to shareholders
31/08/17
PO3 Final Director's Interest Notice
17/08/17
PO3 Initial Director's Interest Notice
17/08/17
PO3 Director Appointment/Resignation
17/08/17
PO3 Appendix 4C
28/07/17PRICE SENSITIVE
PO3 Appendix 4C - Amended
16/05/17
PO3 Appendix 4C - quarterly
01/05/17PRICE SENSITIVE
PO3 Technology Partner Somnio Presents to Flint Water Conference
20/03/17
PO3 Appendix 4C - Amended
06/03/17
PO3 Half Yearly Report and Accounts
27/02/17
PO3 Appendix 4D
27/02/17PRICE SENSITIVE
PO3 Appendix 4C - quarterly
31/01/17PRICE SENSITIVE
PO3 First Ozone Plant shipped for trials
20/12/16PRICE SENSITIVE
PO3 AGM Voting Results
24/11/16
PO3 Market Update AGM
24/11/16PRICE SENSITIVE
PO3 Appendix 4G
14/11/16
PO3 Appendix 4C - quarterly-WRG.AX
28/10/16PRICE SENSITIVE
PO3 Notice of General Meeting/Proxy Form-WRG.AX
25/10/16
PO3 Annual Report to shareholders-WRG.AX
30/09/16
PO3 Preliminary Final Report-WRG.AX
31/08/16PRICE SENSITIVE
PO3 Appendix 4C - quarterly-WRG.AX
29/07/16PRICE SENSITIVE
PO3 Appendix 4C - quarterly-WRG.AX
26/04/16PRICE SENSITIVE
PO3 Market Update-WRG.AX
08/04/16PRICE SENSITIVE
PO3 Half Yearly Report and Accounts
29/02/16
PO3 Appendix 4D
29/02/16PRICE SENSITIVE
PO3 Appendix 4C
29/01/16PRICE SENSITIVE
PO3 Results of Meeting
30/11/15
PO3 Appendix 4C - quarterly
29/10/15PRICE SENSITIVE
PO3 Notice of Annual General Meeting/Proxy Form
28/10/15
PO3 Appendix 4G
01/10/15
PO3 Annual Report to shareholders
30/09/15
PO3 Preliminary Final Report
31/08/15PRICE SENSITIVE
PO3 Appendix 4C - quarterly
28/07/15PRICE SENSITIVE
PO3 Company Secretary Appointment/Resignation
30/06/15
PO3 Results of Meeting
28/05/15
PO3 Market Update
28/05/15
PO3 Notice of Annual General Meeting/Proxy Form
29/04/15
PO3 Quarterly Cashflow Report
28/04/15PRICE SENSITIVE
PO3 Annual Report
31/03/15
PO3 2014 Preliminary Final Report
27/02/15PRICE SENSITIVE
PO3 Market Update
17/02/15PRICE SENSITIVE
PO3 Appendix 4C - quarterly
28/01/15PRICE SENSITIVE
PO3 Market Update and Share Purchase Plan
19/11/14
PO3 Appendix 4C - quarterly
27/10/14PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
22.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $7.078M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
PO3 (ASX) Chart

Top Stories

The iron ore comeback: Can it last?

The Chinese need our iron ore and we could do with the cash if we are sensible enough to put the stuff on a boat and sell it to them.
Hastings progressing Yangibana to production with lower costs Hastings Technology Metals Ltd has released its annual report to shareholders, saying that it has reduced capital costs by $56 million
Zenith's sale of Develin Creek delivers $975K cash, with shares up 13% Zenith Minerals Ltd has completed its sale of Develin Creek copper-zinc project in Queensland to QMines Ltd
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.